This paper describes the structure of the Cost Benefit Model of Diabetes Prevention and Care and lists the data sources used and assumptions embedded in the model. Agnes Walker, Stephen Colagiuri and Michele McLennan validate the model through checks of model outputs against data published by other organisations. They also discuss the sensitivity of model outputs to changes in certain key assumptions.